Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived (HPV) cancer, a virus linked to cervical cancers among others.
The research was published in a recent issue of Cancer Immunology, Immunotherapy.
The authors of the study concluded, "We believe that these studies may help to launch more effective and less invasive therapeutic vaccines for HPV-caused malignancies."
Click here to read more from ScienceDaily.
Click here to read a report on HPV from the Centers of Disease Control and Prevention (CDC).
Suzi Media Production/iStock/Getty Images Plus via Getty Images
